Download
https://www.ndtvprofit.com/markets/ciplas-pithampur-unit-gets-eight-observations-from-us-fda?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
Drug major Cipla said the U.S. health regulator has issued Form 483 with eight observations after inspecting its Pithampur facility.
Share